Open AccessTranexamic acid is beneficial as adjunctive therapy in treating major upper gastrointestinal bleeding in dialysis patients
Author(s) -
Mišo Šabovič,
Janez Lavre,
Bojan Vujkovac
Publication year - 2003
Publication title -
nephrology dialysis transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.654
H-Index - 168
eISSN - 1460-2385
pISSN - 0931-0509
DOI - 10.1093/ndt/gfg117
Subject(s) - medicine , tranexamic acid , dialysis , gastrointestinal bleeding , upper gastrointestinal bleeding , randomized controlled trial , surgery , hemodialysis , anesthesia , gastroenterology , endoscopy , blood loss
In a pilot, non-randomized trial we tested the efficacy of tranexamic acid (TXA), a potent fibrinolytic inhibitor, as adjunctive therapy in standard treatment of major upper gastrointestinal bleeding in dialysis patients.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom